Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diphosgene | HCID 10426 | — |
| Reactant | Tetrahydro-4H-pyran-4-ol | HCID 74956 | — |
| Reactant | HCID 178455378 | HCID 178455378 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 178455382 | HCID 178455382 | — |
Reaction Steps
(trans)-4-(4-(2-((3R,3aR,6R,6aS)-6-(tert-Butyldimethylsilyloxy)hexahydrofuro[3,2-b]furan-3-yloxy)-6-chloro-3-((2-(trimethylsilyl)ethoxy)methyl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)cyclohexanamine (20 mg) is dissolved in toluene (2 mL), treated dropwise with a solution of diphosgene (3.4 μL) in toluene (1 mL) and stirred for 12 hours at 60° C. Tetrahydro-2H-pyran-4-ol (2.7 μL) is added and the mixture is heated for 12 hours at 60° C. The mixture is partitioned between ethylacetate and saturated aqueous NH4Cl solution. The organic phase is washed with brine, dried (MgSO4) and concentrated to give the title compound. LC (method 5): tR=1.22 min.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09187477B2 |
|---|
| Source dataset | uspto-grants-2015_11 |
|---|
| ORD ID | ord-e688e89b9117400082d53ca895429417 |
|---|
| Source note | uspto-grants-2015_11 |
|---|